British Journal of Dermatology

Research Snippets
pp. i-i(1)

Benzoyl peroxide and adapalene fixed combination: a novel agent for acne
pp. 971-976(6)

Malignant melanoma: how error amplification by screening creates spurious disease
pp. 977-979(3)
Author: Shuster, S.

Lipoedema: from clinical presentation to therapy. A review of the literature
pp. 980-986(7)
Authors: Langendoen, S.I.; Habbema, L.; Nijsten, T.E.C.; Neumann, H.A.M.

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
pp. 987-1019(33)
Authors: Smith, C.H.; Anstey, A.V.; Barker, J.N.W.N.; Burden, A.D.; Chalmers, R.J.G.; Chandler, D.A.; Finlay, A.Y.; Griffiths, C.E.M.; Jackson, K.; McHugh, N.J.; McKenna, K.E.; Reynolds, N.J.; Ormerod, A.D.

Nicotine enhances skin necrosis and expression of inflammatory mediators in a rat pressure ulcer model
pp. 1020-1027(8)
Authors: Tsutakawa, S.; Kobayashi, D.; Kusama, M.; Moriya, T.; Nakahata, N.

In vitro model for penetration of sensory nerve fibres on a Matrigel basement membrane: implications for possible application to intractable pruritus
pp. 1028-1037(10)
Authors: Tominaga, M.; Kamo, A.; Tengara, S.; Ogawa, H.; Takamori, K.

Molecular detection of dermatophytes and nondermatophytes in onychomycosis by nested polymerase chain reaction based on 28S ribosomal RNA gene sequences
pp. 1038-1044(7)
Authors: Ebihara, M.; Makimura, K.; Sato, K.; Abe, S.; Tsuboi, R.

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
pp. 1045-1051(7)
Authors: Lee, W.J.; Lee, J.L.; Chang, S.E.; Lee, M.W.; Kang, Y.K.; Choi, J.H.; Moon, K.C.; Koh, J.K.

Scar classification in cutaneous lupus erythematosus: morphological description
pp. 1052-1058(7)
Authors: Al-Refu, K.; Goodfield, M.

The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin
pp. 1059-1066(8)
Authors: Kjellerup, R.B.; Iversen, L.; Kragballe, K.; Johansen, C.

A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer
pp. 1067-1071(5)
Authors: Prior, S.L.; Griffiths, A.P.; Lewis, P.D.

Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis
pp. 1072-1080(9)
Authors: Ishiuji, Y.; Coghill, R.C.; Patel, T.S.; Oshiro, Y.; Kraft, R.A.; Yosipovitch, G.

Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments
pp. 1081-1088(8)
Authors: Seneschal, J.; Milpied, B.; Vergier, B.; Lepreux, S.; Schaeverbeke, T.; Taïeb, A.

Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort
pp. 1089-1097(9)
Authors: Kern, J.S.; Grüninger, G.; Imsak, R.; Müller, M.L.; Schumann, H.; Kiritsi, D.; Emmert, S.; Borozdin, W.; Kohlhase, J.; Bruckner-Tuderman, L.; Has, C.

Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods
pp. 1098-1104(7)
Authors: Kezic, S.; Kammeyer, A.; Calkoen, F.; Fluhr, J.W.; Bos, J.D.

Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity
pp. 1105-1111(7)
Authors: Fongers, A.; Wolkerstorfer, A.; Nieuweboer-Krobotova, L.; Krawczyk, P.; Tóth, G.G.; van der Veen, J.P.W.

MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma
pp. 1112-1118(7)
Authors: Toll, A.; Salgado, R.; Yébenes, M.; Martín-Ezquerra, G.; Gilaberte, M.; Baró, T.; Solé, F.; Alameda, F.; Espinet, B.; Pujol, R.M.

Inverse relationship between contact allergy and psoriasis: results from a patient- and a population-based study
pp. 1119-1123(5)
Authors: Bangsgaard, N.; Engkilde, K.; Thyssen, J.P.; Linneberg, A.; Nielsen, N.H.; Menné, T.; Skov, L.; Johansen, J.D.

Contact allergy to allergens of the TRUE-test (panels 1 and 2) has decreased modestly in the general population
pp. 1124-1129(6)
Authors: Thyssen, J.P.; Linneberg, A.; Menné, T.; Nielsen, N.H.; Johansen, J.D.

Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes
pp. 1130-1135(6)
Authors: Blömeke, B.; Brans, R.; Coenraads, P.-J.; Dickel, H.; Bruckner, T.; Hein, D.W.; Heesen, M.; Merk, H.-F.; Kawakubo, Y.

Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus
pp. 1136-1142(7)
Authors: Gambichler, T.; Skrygan, M.; Tigges, C.; Kobus, S.; Gläser, R.; Kreuter, A.

Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool
pp. 1143-1148(6)
Authors: Blome, C.; Augustin, M.; Siepmann, D.; Phan, N.Q.; Rustenbach, S.J.; Ständer, S.

A population-based study of acute medical conditions associated with bullous pemphigoid
pp. 1149-1152(4)
Authors: Langan, S.M.; Hubbard, R.; Fleming, K.; West, J.

Hereditary angio-oedema in Denmark: a nationwide survey
pp. 1153-1158(6)
Author: Bygum, A.

CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals
pp. 1159-1165(7)
Authors: Alvarez, F.; Meyer, N.; Gourraud, P.A.; Paul, C.

Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors
pp. 1166-1172(7)
Authors: Wen, H-J.; Chen, P-C.; Chiang, T-L.; Lin, S-J.; Chuang, Y-L.; Guo, Y-L.

Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema
pp. 1173-1179(7)
Authors: Mikolajewska, P.; Iani, V.; Juzeniene, A.; Moan, J.

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients
pp. 1180-1189(10)
Authors: Gollnick, H.P.M.; Draelos, Z.; Glenn, M.J.; Rosoph, L.A.; Kaszuba, A.; Cornelison, R.; Gore, B.; Liu, Y.; Graeber, M.

Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept
pp. 1190-1195(6)
Authors: Ortonne, J.-P.; Taïeb, A.; Ormerod, A.D.; Robertson, D.; Foehl, J.; Pedersen, R.; Molta, C.; Freundlich, B.

Elevated aldosterone levels in patients with androgenetic alopecia
pp. 1196-1198(3)
Authors: Arias-Santiago, S.; Gutiérrez-Salmerón, M.T.; Castellote-Caballero, L.; Naranjo-Sintes, R.

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
pp. 1199-1201(3)
Authors: Brenner, M.; Ruzicka, T.; Plewig, G.; Thomas, P.; Herzer, P.

A novel PTPN11 missense mutation in a patient with LEOPARD syndrome
pp. 1202-1204(3)
Authors: Osawa, R.; Akiyama, M.; Yamanaka, Y.; Ujiie, H.; Nemoto-Hasebe, I.; Takeda, A.; Yanagi, T.; Shimizu, H.

Methotrexate for sclerotic skin disorders: no evidence for effectiveness
pp. 1205-1205(1)
Authors: Jessop, S.; Whitelaw, D.

Peripheral regional aseptic neutrophilic lymphadenopathy associated with pyoderma gangrenosum
pp. 1206-1207(2)
Authors: Al-Niaimi, F.; Cox, N.H.

Evidence for an `anti-ageing' product may not be so clear as it appears
pp. 1207-1208(2)
Author: Bland, J.M.

Evidence for an `anti-ageing' product may not be so clear as it appears: reply from authors
pp. 1208-1209(2)
Authors: Watson, R.E.B.; Griffiths, C.E.M.

Etanercept and infections
pp. 1209-1210(2)
Author: Bertouch, J.

Etanercept and infections: reply from authors
pp. 1210-1211(2)
Author: van deKerkhof, P.C.M.

News and Notices
pp. 1211-1211(1)